Ping J.

Ping J. has over 16 years of experience in the biotechnology industry. From 2022 to present, Ping has served as the Senior Director at Fore Biotherapeutics. From 2017 to 2022, Ping was the Director of Translational Science at Incyte. From 2011 to 2017, Ping was the Associate Director of Translational Clinical Science, Oncology and Translational Biology at Halozyme Therapeutics, Inc. In this role, Ping led the companion diagnostic development to identify and evaluate biomarkers of targeted therapy for oncology drug development, managed and directed a team of four PhD scientists, and completed tests of Phase 1 clinical biopsies for Hyaluronan content using IHC based assay. From 2009 to 2011, Ping was a Senior Scientist II at Halozyme Therapeutics. From 2005 to 2009, Ping was a Senior Scientist I at Halozyme Therapeutics, Inc.

Ping J. has a background in Kunming Medical College. They also have a certification in Clinical Trial Design and Management from the University of California, San Diego.